2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Injection Pens

2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Injection Pens

Regular Price: USD 10,000

Special Price USD 7,000

30% OFF

* Required Fields

Regular Price: USD 10,000

Special Price USD 7,000

PAY BY INVOICE

Be the first to review this product

Type 2 diabetes is the most common form of diabetes. It is a chronic disease marked by high levels of glucose in the blood. The primary goal to treat type 2 diabetes is diet and exercise. However, if diet and exercise does not help maintain normal glucose levels, physicians may prescribe medication.

A sample size of 1,002 adult type 2 diabetes patients who use an injection pen to administer their medication into their bodies to regulate their disease were surveyed to assess their awareness, usage, and preferences of injection pens.

Table of Contents

2010 U.S. Type 2 Diabetes Patients' Choice, 2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Injection Pens2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Injection Pens2010 U.S. Type 2 Diabetes Patients' Choice of Injection Pens




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.